For instance, 3-deazaneplanocin A (DZNep) robustly impedes the self-renewal and tumor-forming capabilities of GBM stem cells by inducing pharmacological disruption of EZH2 (Suva et al., 2009). Here, EZH2 is linked to glioblastoma.